EUVIMEDEUVIMED entdecken
Open Access

Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways

Junyue Fang, Rui Xu, Yuan Cao, Zixuan Zhao, Weifan Li, Li Lin, Jingyi Hou, Xiaoding Xu, Phei Er Saw

Theranostics · 2025

DOI: 10.7150/thno.112649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Junyue Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Y…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Mitophagy, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2MitophagyImmunotherapyNanoparticlesUltrasonic TherapyAnimalsMiceHumansReactive Oxygen SpeciesCell Line, TumorFemaleRNA, Small InterferingRNA InterferenceSignal TransductionOxidation-ReductionAdenine

Stichwörter der Autor:innen

immune checkpoint blockademitophagy inhibitionreactive oxygen speciesredox-responsive nanoplatformsonoimmunotherapy

Substanzen

NF-E2-Related Factor 2Reactive Oxygen SpeciesRNA, Small InterferingNFE2L2 protein, humanAdenine

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
  • Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan 528200, P. R. China.
  • Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
  • Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
  • Department of Orthopedics and Department of Sports Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.

Zitieren

APA

Fang, J., Xu, R., Cao, Y., Zhao, Z., Li, W., Lin, L., Hou, J., Xu, X., & Saw, P. E. (2025). Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways. Theranostics. https://doi.org/10.7150/thno.112649

Vancouver

Fang J, Xu R, Cao Y, Zhao Z, Li W, Lin L, et al. Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways. Theranostics. 2025. doi:10.7150/thno.112649

BibTeX
@article{Fang2025,
  author = {Fang, Junyue and Xu, Rui and Cao, Yuan and Zhao, Zixuan and Li, Weifan and Lin, Li and Hou, Jingyi and Xu, Xiaoding and Saw, Phei Er},
  title = {Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.112649}
}
Kostenlos starten →